Cardiac biomarkers of choice for diagnosis of myocardial infraction 10 days after initial event
Ref Harrison 19 th ed pg 1594 addition to the clinical examination, three major noninvasive tools are used in the evaluation of NSTEMI-ACS: the electrocardiogram (ECG), cardiac biomarkers, and stress testing. CCTA is an additional emerging option The goals are to: (1) recognize or exclude myocardial infarction (MI) using cardiac biomarkers, preferably cTn;
Troponins
CK-MB
Myoglobin
LDH
C.V.S